AMNEAL PHARMACEUTICALS, INC. Other Non-Current Liabilities
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Other Non-Current Liabilities of $41.46 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-05-09
- 2023-03-31: Other Liabilities, Noncurrent $41.46M.
- 2022-12-31: Other Liabilities, Noncurrent $87.47M.
- 2022-09-30: Other Liabilities, Noncurrent $78.26M.
- 2022-06-30: Other Liabilities, Noncurrent $79.21M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-03-31 | $41.46M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $87.47M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $78.26M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $79.21M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $32.87M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $38.90M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $60.80M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $63.26M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $63.79M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $83.36M 10-K · filed 2022-03-01 | $85.68M 10-K · filed 2021-03-01 |
| 2020-09-30 | $96.19M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $93.77M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $80.85M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $39.58M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $38.53M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $28.65M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $37.72M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $38.78M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $44.77M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $45.67M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $7.79M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |